Intratumoral expression of respiratory syncytial virus fusion protein in combination with cytokines encoded by adenoviral vectors as in situ tumor vaccine for colorectal cancer

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Molecular Cancer Therapeutics

• Publication date

  2007-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1535-7163.MCT-06-0790PMID 17620425
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-2 for the treatment of solid tumors other than melanoma and renal cell carcinoma

  2006cited by this paper
• Replication Properties of Human Adenovirus In Vivo and in Cultures of Primary Cells from Different Animal Species

  2006cited by this paper
• Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy.

  2006cited by this paper
• Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell priming

  2006cited by this paper
• IL-21 Induces Differentiation of Human Naive and Memory B Cells into Antibody-Secreting Plasma Cells1

  2005cited by this paper
• Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients.

  2005cited by this paper
• Vaccination of Advanced Hepatocellular Carcinoma Patients with Tumor Lysate-Pulsed Dendritic Cells: A Clinical Trial

  2005cited by this paper
• Recombinant Adenovirus Vector Vaccine Induces Stronger Cytotoxic T-Cell Responses Than Recombinant Vaccinia Virus Vector, Plasmid DNA, or a Combination of These

  2005cited by this paper
• Enhancement of the efficacy of chemotherapy with oxaliplatin plus 5-fluorouracil by pretreatment with IL-2 subcutaneous immunotherapy in metastatic colorectal cancer patients with lymphocytopenia prior to therapy.

  2005cited by this paper
• Combined immunocell therapy using activated lymphocytes and monocyte-derived dendritic cells for malignant melanoma.

  2005cited by this paper
• Augmentation of Antitumor Immune Responses by Multiple Intratumoral Inoculations of Replication-Conditional HSV and Interleukin-12

  2004cited by this paper
• Trans‐complementing adenoviral vectors for oncolytic therapy of malignant melanoma

  2004cited by this paper
• Biology of IL‐21 and the IL‐21 receptor

  2004cited by this paper
• Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses

  2004cited by this paper
• Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy

  2003cited by this paper
• Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer model.

  2003cited by this paper
• Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model.

  2002cited by this paper
• Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion.

  2002cited by this paper
• Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells.

  2002cited by this paper
• Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells

  2001cited by this paper
• Use of Viral Fusogenic Membrane Glycoproteins as Novel Therapeutic Transgenes in Gliomas

  2001cited by this paper
• Interleukin-18 regulates both Th1 and Th2 responses.

  2001cited by this paper
• Human Immunodeficiency Virus Type 1-Mediated Syncytium Formation Is Compatible with Adenovirus Replication and Facilitates Efficient Dispersion of Viral Gene Products and De Novo-Synthesized Virus Particles

  2001cited by this paper
• Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression.

  2000cited by this paper
• Genetically Determined Disparate Innate and Adaptive Cell-Mediated Immune Responses to Pulmonary Mycobacterium bovis BCG Infection in C57BL/6 and BALB/c Mice

  2000cited by this paper
• A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

  2000cited by this paper
• Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

  2000cited by this paper
• Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth.

  2000cited by this paper
• Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

  2000cited by this paper
• In vivo immunomodulation following intradermal injection with DNA encoding IL-18.

  1999cited by this paper
• Herpes Simplex Virus as an in Situ Cancer Vaccine for the Induction of Specific Anti-Tumor Immunity

  1999cited by this paper
• Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

  1999cited by this paper
• Preparation of frozen sections for analysis.

  1999cited by this paper
• Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death.

  1999cited by this paper
• A simplified system for generating recombinant adenoviruses.

  1998cited by this paper
• Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines

  1996cited by this paper
• Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy

  1996cited by this paper
• Human tumor antigens recognized by T lymphocytes

  1996cited by this paper
• Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines.

  1996cited by this paper
• Cytometric detection and quantitation of cell-cell electrofusion products.

  1995cited by this paper
• Interleukin-12. Biologic activity, therapeutic utility, and role in disease.

  1995cited by this paper
• A Phase II Trial of Interleukin‐2 and Interferon‐α in the Treatment of Metastatic Colorectal Carcinoma

  1995cited by this paper
• Interleukin-12. Biologic activity, therapeutic utility, and role in disease.

  1995cited by this paper
• A phase II trial of interleukin-2 and interferon-alpha in the treatment of metastatic colorectal carcinoma.

  1995cited by this paper
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

  1994cited by this paper
• The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen.

  1992cited by this paper
• Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. II. Production of interleukins 2, 4, and 6 and of interferon-gamma by draining lymph node cells.

  1991cited by this paper
• Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. I. Analysis of cell surface phenotype in local granulomas.

  1990cited by this paper
• Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy.

  1989cited by this paper
• Experience with the Use of High‐Dose Interleukin‐2 in the Treatment of 652 Cancer Patients

  1989cited by this paper
• Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection.

  1987cited by this paper
• Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells.

  1987cited by this paper
• Antibody development to viral and allogeneic tumor cell-associated antigens in patients with malignant melanoma and ovarian carcinoma treated with lysates of virus-infected tumor cells.

  1986cited by this paper
• Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity.

  1986cited by this paper
• Augmented immunogenicity of Lewis lung carcinoma by infection with herpes simplex virus type 2.

  1982cited by this paper
• Immunohistology of the antigenic pattern of a continuous cell line from a human colon tumor.

  1975cited by this paper

• The influence of cell-cell fusion on cancer heterogeneity and its promise for targeted treatments

  2026cites this paper
• Development and Characterization of an Oncolytic Human Adenovirus-Based Vector Co-Expressing the Adenovirus Death Protein and p14 Fusion-Associated Small Transmembrane Fusogenic Protein

  2024cites this paper
• The genome position of a therapeutic transgene strongly influences the level of expression in an armed oncolytic human adenovirus vector.

  2021cites this paper
• Strategies for enhancing intratumoral spread of oncolytic adenoviruses.

  2020cites this paper
• Use of cell fusion proteins to enhance adenoviral vector efficacy as an anti-cancer therapeutic

  2020cites this paper
• Enhancing Oncolytic Adenovirus Vector Efficacy through Co-expression of the p14 Fusion-associated Small Transmembrane Protein and Adenovirus Death Protein

  2018influential citation
• Adenoviral Vectors Armed with Cell Fusion-Inducing Proteins as Anti-Cancer Agents

  2017influential citation
• Expression of the fusogenic p14 FAST protein from a replication-defective adenovirus vector does not provide a therapeutic benefit in an immunocompetent mouse model of cancer

  2016cites this paper
• Adenovirus-Mediated Expression of the p14 Fusion-Associated Small Transmembrane Protein Promotes Cancer Cell Fusion and Apoptosis In Vitro but Does Not Provide Therapeutic Efficacy in a Xenograft Mouse Model of Cancer

  2016cites this paper
• Improving Adenovirus Efficacy with p14 Fusion Associated Small Transmembrane Protein Expression for Cancer Treatment

  2015influential citation
• IL-18 Is Involved in Eosinophil-Mediated Tumoricidal Activity against a Colon Carcinoma Cell Line by Upregulating LFA-1 and ICAM-1

  2015cites this paper
• and ICAM-1 Carcinoma Cell Line by Upregulating LFA-1 Tumoricidal Activity against a Colon IL-18 Is Involved in Eosinophil-Mediated

  2015cites this paper
• CPEB1, a histone-modified hypomethylated gene, is regulated by miR-101 and involved in cell senescence in glioma

  2013cites this paper
• Gene Silencing and Polycomb Group Proteins: An Overview of their Structure, Mechanisms and Phylogenetics

  2013cites this paper
• Identification and characterization of novel indole based small molecules as anticancer agents through SIRT1 inhibition.

  2013cites this paper
• Epigenetic Mechanisms: Histone Acetylation, DNA Methylation, miRNA, Chromatin Modifiers

  2013cites this paper
• Alterations in Promoter Methylation Status of Tumor Suppressor HIC1, SFRP2, and DAPK1 Genes in Prostate Carcinomas

  2012cites this paper
• Fusogenic oncolytic herpes simplex viruses as a potent and personalized cancer vaccine.

  2012cites this paper
• DNA methylation changes in prostate cancer.

  2012cites this paper
• Epigenetic Mechanisms in Commonly Occurring Cancers

  2012cites this paper
• The Impact of Epigenetic Alterations on Diagnosis, Prediction, and Therapy of Prostate Cancer

  2012cites this paper
• Replication-competent adenovirus 11p vector as a new oncolytic agent

  2011cites this paper
• Inverse association of p16INK4a and p14ARF methylation of the CDKN2a locus in different Gleason scores of prostate cancer

  2011cites this paper
• Oncolytic virotherapy as a personalized cancer vaccine

  2008cites this paper
• MINI REVIEW Oncolytic virotherapy as a personalized cancer vaccine

  2008cites this paper
• Immune-mediated anti-neoplastic effect of intratumoral RSV envelope glycoprotein expression is related to apoptotic death of tumor cells but not to the size of syncytia.

  2008cites this paper
• Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen

  2008cites this paper
• Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers

  2008cites this paper
• Saccharomyces cerevisiae, the Baker’s Yeast, suppresses the growth of Ehrlich carcinoma-bearing mice

  2008cites this paper